Literature DB >> 9474170

Cost-effective hydrocele ablation.

J A Fracchia1, N A Armenakas, A D Kohan.   

Abstract

PURPOSE: The surgical repair of hydroceles can be relatively expensive in some cases in terms of costs and initial limitation of activity. We ascertain whether aspiration and sclerotherapy of hydroceles is a safe, efficient, cost-effective treatment modality in select patients.
MATERIALS AND METHODS: In 47 patients 51 hydroceles were treated in the office with aspiration and instillation of a sclerosing solution based on a sodium tetradecyl sulfate preparation. One treatment was done in 14 cases and 2 in the remainder. Medicare data for 1995 were used for charge analysis.
RESULTS: The overall success rate was 61% (34 of 51 cases) with success defined as no perceptible ipsilateral scrotal fluid reaccumulation on palpation by a physician and complete patient satisfaction. The failure rate was 39% (17 cases) with failure defined as perceptible ipsilateral scrotal fluid reaccumulation on palpation by a physician and/or patient dissatisfaction. The charge differential of surgery versus aspiration and sclerotherapy was greater than 9:1.
CONCLUSIONS: The aspiration and sclerotherapy technique that we used appears to be an efficacious, safe, cost-effective treatment modality in select patients with idiopathic hydroceles.

Entities:  

Mesh:

Year:  1998        PMID: 9474170

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

Review 1.  Management of hydrocele in adolescent patients.

Authors:  Marcello Cimador; Marco Castagnetti; Enrico De Grazia
Journal:  Nat Rev Urol       Date:  2010-06-15       Impact factor: 14.432

Review 2.  Laparoscopic totally extraperitoneal versus open preperitoneal mesh repair for inguinal hernia recurrence: a decision analysis based on net health benefits.

Authors:  George Sgourakis; Georgia Dedemadi; Ines Gockel; Irene Schmidtmann; Sophocles Lanitis; Paraskevi Zaphiriadou; Athanasios Papatheodorou; Constantine Karaliotas
Journal:  Surg Endosc       Date:  2013-01-24       Impact factor: 4.584

3.  Sclerotherapy for hydrocele revisited: a prospective randomised study.

Authors:  M S Agrawal; H Yadav; A Upadhyay; R Jaiman; J Singhal; A K Singh
Journal:  Indian J Surg       Date:  2009-03-13       Impact factor: 0.656

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.